NMNAT-1 Activators

Chemical compounds categorized as NMNAT-1 Activators comprise a diverse group of molecules that can indirectly influence the activity of Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 (NMNAT-1). These compounds primarily function by modulating the availability of substrates or influencing the demand for NAD+, the essential molecule whose biosynthesis is catalyzed by NMNAT-1. This category includes both precursors in the NAD+ biosynthesis pathway and modulators of pathways that consume or require NAD+.

Nicotinamide, nicotinic acid, and nicotinamide riboside are direct precursors in the NAD+ biosynthesis pathway. Their increased availability can enhance the substrate pool for NMNAT-1, potentially boosting its activity. Resveratrol and other sirtuin activators increase the demand for NAD+ by activating NAD+-dependent enzymes, indirectly influencing NMNAT-1 activity to meet this increased demand. Similarly, compounds like pyrroloquinoline quinone (PQQ) and quercetin, which affect mitochondrial function and cellular antioxidant systems, can indirectly impact NMNAT-1 through changes in cellular NAD+ metabolism. Moreover, broader metabolic influencers like AMPK activators, caloric restriction mimetics, and ketone bodies play a role in modulating cellular energy status and metabolic pathways. These changes can indirectly affect NMNAT-1 activity by altering NAD+ levels and demands within the cell. Inhibition of PARP enzymes, which also consume NAD+, represents another indirect method of increasing NAD+ availability, potentially enhancing NMNAT-1 activity.